Literature DB >> 25326399

Intermediate Charcot-Marie-Tooth disease.

Lei Liu1, Ruxu Zhang2.   

Abstract

Charcot-Marie-Tooth (CMT) disease is a common neurogenetic disorder and its heterogeneity is a challenge for genetic diagnostics. The genetic diagnostic procedures for a CMT patient can be explored according to the electrophysiological criteria: very slow motor nerve conduction velocity (MNCV) (<15 m/s), slow MNCV (15-25 m/s), intermediate MNCV (25-45 m/s), and normal MNCV (>45 m/s). Based on the inheritance pattern, intermediate CMT can be divided into dominant (DI-CMT) and recessive types (RI-CMT). GJB1 is currently considered to be associated with X-linked DI-CMT, and MPZ, INF2, DNM2, YARS, GNB4, NEFL, and MFN2 are associated with autosomal DI-CMT. Moreover, GDAP1, KARS, and PLEKHG5 are associated with RI-CMT. Identification of these genes is not only important for patients and families but also provides new information about pathogenesis. It is hoped that this review will lead to a better understanding of intermediate CMT and provide a detailed diagnostic procedure for intermediate CMT.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25326399      PMCID: PMC5562560          DOI: 10.1007/s12264-014-1475-7

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  80 in total

1.  G proteins: more than transducers of receptor-generated signals?

Authors:  Stefan Engelhardt; Francesca Rochais
Journal:  Circ Res       Date:  2007-04-27       Impact factor: 17.367

2.  Dominant mutations in the tyrosyl-tRNA synthetase gene recapitulate in Drosophila features of human Charcot-Marie-Tooth neuropathy.

Authors:  Erik Storkebaum; Ricardo Leitão-Gonçalves; Tanja Godenschwege; Leslie Nangle; Monica Mejia; Inge Bosmans; Tinne Ooms; An Jacobs; Patrick Van Dijck; Xiang-Lei Yang; Paul Schimmel; Koen Norga; Vincent Timmerman; Patrick Callaerts; Albena Jordanova
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-26       Impact factor: 11.205

3.  Charcot-Marie-Tooth disease with intermediate conduction velocities caused by a novel mutation in the MPZ gene.

Authors:  Isabel Banchs; Carlos Casasnovas; Jordi Montero; Victor Volpini; Juan Antonio Martínez-Matos
Journal:  Muscle Nerve       Date:  2010-08       Impact factor: 3.217

Review 4.  Axonal Charcot-Marie-Tooth disease.

Authors:  Michael E Shy; Agnes Patzkó
Journal:  Curr Opin Neurol       Date:  2011-10       Impact factor: 5.710

5.  Mitochondrial and axonal abnormalities precede disruption of the neurofilament network in a model of charcot-marie-tooth disease type 2E and are prevented by heat shock proteins in a mutant-specific fashion.

Authors:  Miranda L Tradewell; Heather D Durham; Walter E Mushynski; Benoit J Gentil
Journal:  J Neuropathol Exp Neurol       Date:  2009-06       Impact factor: 3.685

6.  A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease.

Authors:  Philippe Latour; Christel Thauvin-Robinet; Chantal Baudelet-Méry; Pierre Soichot; Veronica Cusin; Laurence Faivre; Marie-Claire Locatelli; Martine Mayençon; Annie Sarcey; Emmanuel Broussolle; William Camu; Albert David; Robert Rousson
Journal:  Am J Hum Genet       Date:  2009-12-31       Impact factor: 11.025

7.  A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: clinical and pathological findings.

Authors:  Marc Bitoun; Tanya Stojkovic; Bernard Prudhon; Claude-Alain Maurage; Philippe Latour; Patrick Vermersch; Pascale Guicheney
Journal:  Neuromuscul Disord       Date:  2008-04-03       Impact factor: 4.296

8.  Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis.

Authors:  Elizabeth J Brown; Johannes S Schlöndorff; Daniel J Becker; Hiroyasu Tsukaguchi; Stephen J Tonna; Andrea L Uscinski; Henry N Higgs; Joel M Henderson; Martin R Pollak
Journal:  Nat Genet       Date:  2009-12-20       Impact factor: 38.330

9.  Intermediate Charcot-Marie-Tooth disease due to a novel Trp101Stop myelin protein zero mutation associated with debilitating neuropathic pain.

Authors:  Juan D Ramirez; Phillip R J Barnes; Kerry R Mills; David L H Bennett
Journal:  Pain       Date:  2012-06-16       Impact factor: 6.961

10.  Mutations in the PLEKHG5 gene is relevant with autosomal recessive intermediate Charcot-Marie-Tooth disease.

Authors:  Hyeon Jin Kim; Young Bin Hong; Jin-Mo Park; Yu-Ri Choi; Ye Jin Kim; Bo Ram Yoon; Heasoo Koo; Jeong Hyun Yoo; Sang Beom Kim; Minhwa Park; Ki Wha Chung; Byung-Ok Choi
Journal:  Orphanet J Rare Dis       Date:  2013-07-12       Impact factor: 4.123

View more
  6 in total

1.  NEFL E396K mutation is associated with a novel dominant intermediate Charcot-Marie-Tooth disease phenotype.

Authors:  José Berciano; Antonio García; Kristien Peeters; Elena Gallardo; Els De Vriendt; Ana L Pelayo-Negro; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2015-04-01       Impact factor: 4.849

Review 2.  Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.

Authors:  José Berciano; Antonio García; Elena Gallardo; Kristien Peeters; Ana L Pelayo-Negro; Silvia Álvarez-Paradelo; José Gazulla; Miriam Martínez-Tames; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2017-03-31       Impact factor: 4.849

Review 3.  Inverted formins: A subfamily of atypical formins.

Authors:  Anna Hegsted; Curtis V Yingling; David Pruyne
Journal:  Cytoskeleton (Hoboken)       Date:  2017-09-29

4.  NEFL N98S mutation: another cause of dominant intermediate Charcot-Marie-Tooth disease with heterogeneous early-onset phenotype.

Authors:  José Berciano; Kristien Peeters; Antonio García; Tomás López-Alburquerque; Elena Gallardo; Arantxa Hernández-Fabián; Ana L Pelayo-Negro; Els De Vriendt; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2015-12-08       Impact factor: 4.849

5.  Functional Characterization of Neurofilament Light Splicing and Misbalance in Zebrafish.

Authors:  Doris Lou Demy; Maria Letizia Campanari; Raphael Munoz-Ruiz; Heather D Durham; Benoit J Gentil; Edor Kabashi
Journal:  Cells       Date:  2020-05-16       Impact factor: 6.600

Review 6.  Ascorbic acid for the treatment of Charcot-Marie-Tooth disease.

Authors:  Burkhard Gess; Jonathan Baets; Peter De Jonghe; Mary M Reilly; Davide Pareyson; Peter Young
Journal:  Cochrane Database Syst Rev       Date:  2015-12-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.